Publications by authors named "Ralph B Arlinghaus"

35Publications

Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines.

Adv Biol Regul 2018 08 18;69:43-62. Epub 2018 May 18.

Department of Microbiology & Immunology, Brody School of Medicine, East Carolina University, Greenville, NC, 27834, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbior.2018.05.002DOI Listing
August 2018

Combination of JAK2 and HSP90 inhibitors: an effective therapeutic option in drug-resistant chronic myelogenous leukemia.

Genes Cancer 2016 May;7(5-6):201-208

Department of Translational Molecular Pathology, M.D. Anderson Cancer Center, University of Texas, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/genesandcancer.111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979592PMC
May 2016

Effective Concentration of a Multikinase Inhibitor within Bone Marrow Correlates with In Vitro Cell Killing in Therapy-Resistant Chronic Myeloid Leukemia.

Mol Cancer Ther 2016 05 4;15(5):899-910. Epub 2016 Feb 4.

Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas. Department of Cell and Developmental Biology, Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065108PMC
http://dx.doi.org/10.1158/1535-7163.MCT-15-0577-TDOI Listing
May 2016

The Sox4/Tcf7l1 axis promotes progression of BCR-ABL-positive acute lymphoblastic leukemia.

Haematologica 2014 Oct 4;99(10):1591-8. Epub 2014 Jul 4.

Department of Laboratory Medicine and the Center for Stem Cell and Developmental Biology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2014.104695DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181255PMC
October 2014

c-Abl activates janus kinase 2 in normal hematopoietic cells.

J Biol Chem 2014 Aug 12;289(31):21463-72. Epub 2014 Jun 12.

From the Department of Translational Molecular Pathology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M114.554501DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118109PMC
August 2014

Multiplexed volumetric bar-chart chip for point-of-care diagnostics.

Nat Commun 2012 ;3:1283

Department of Nanomedicine, The Methodist Hospital Research Institute, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms2292DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266136PMC
June 2013

Inhibition of the NADPH oxidase regulates heme oxygenase 1 expression in chronic myeloid leukemia.

Cancer 2012 Jul 2;118(13):3433-45. Epub 2011 Dec 2.

Department of Pediatrics Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.26621DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297684PMC
July 2012

Relationships of lipocalin 2 with breast tumorigenesis and metastasis.

J Cell Physiol 2011 Feb;226(2):309-14

Department of Molecular Pathology, MD Anderson Cancer Center, University of Texas, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.22403DOI Listing
February 2011

WITHDRAWN: Requirement of lipocalin 2 in breast cancer.

Adv Enzyme Regul 2009 Nov 13. Epub 2009 Nov 13.

Department of Molecular Pathology, The University of Texas M.D. Anderson Cancer Center, 7435 Fannin St., Unit 951, Houston, TX 77030, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.advenzreg.2009.10.001DOI Listing
November 2009

Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis.

Cancer Res 2009 Nov 3;69(22):8579-84. Epub 2009 Nov 3.

Department of Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-09-1934DOI Listing
November 2009

Tissue-resident stem cells promote breast cancer growth and metastasis.

Carcinogenesis 2009 Apr 30;30(4):589-97. Epub 2009 Jan 30.

Department of Molecular Pathology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgp036DOI Listing
April 2009

Preparation and application of polyclonal and monoclonal sequence-specific anti-phosphoamino acid antibodies.

Curr Protoc Protein Sci 2004 Feb;Chapter 13:Unit 13.6

University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/0471140864.ps1306s34DOI Listing
February 2004

BCR-ABL1 mediates up-regulation of Fyn in chronic myelogenous leukemia.

Blood 2008 Mar 7;111(5):2904-8. Epub 2008 Jan 7.

Department of Pediatrics Research, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-05-091769DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2254539PMC
March 2008

Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate.

Cancer Cell 2006 Sep;10(3):241-52

Department of Molecular Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccr.2006.08.009DOI Listing
September 2006

Janus kinase 2: a critical target in chronic myelogenous leukemia.

Cancer Res 2006 Jul;66(13):6468-72

Department of Molecular Pathology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-06-0025DOI Listing
July 2006

Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice.

Cancer Res 2005 Apr;65(7):2532-6

Department of Molecular Pathology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-04-2425DOI Listing
April 2005

Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53.

Nat Genet 2004 Jan 14;36(1):55-62. Epub 2003 Dec 14.

Department of Molecular Pathology, Division of Pathology & Laboratory Medicine, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/ng1279
Publisher Site
http://dx.doi.org/10.1038/ng1279DOI Listing
January 2004

Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer.

Cancer Res 2003 Aug;63(15):4724-30

Department of Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
August 2003

The c-Myc Oncoprotein Interacts with Bcr.

Curr Biol 2003 Mar;13(5):437-41

Department of Microbiology and Molecular Genetics, UMDNJ-New Jersey Medical School, PO Box 1709, 225 Warren Street, Newark, NJ 07101-1709, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0960-9822(03)00090-3DOI Listing
March 2003

Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr.

Cancer Res 2003 Jan;63(2):298-303

Department of Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
January 2003

Bcr: a negative regulator of the Bcr-Abl oncoprotein in leukemia.

Oncogene 2002 Dec;21(56):8560-7

Department of Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1206083DOI Listing
December 2002

Jak2 is involved in c-Myc induction by Bcr-Abl.

Oncogene 2002 Oct;21(47):7137-46

Department of Molecular Pathology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1205942DOI Listing
October 2002

Inhibition of the Bcr-Abl oncoprotein by Bcr requires phosphoserine 354.

Cancer Res 2002 Jan;62(2):386-90

Department of Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
January 2002